LMAT
LeMaitre Vascular Inc
NASDAQ: LMAT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$101.64
+0.98% today
Updated 2026-06-05
Market cap
$2.16B
P/E ratio
34.80
P/S ratio
8.44x
EPS (TTM)
$2.72
Dividend yield
0.90%
52W range
$78 – $118
Volume
0.2M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A8.5
Quality
A8.0
Profitability
A2.7
Valuation
F4/9
Piotroski F-Score
Moderate
3.2
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$118.75
+16.83%
12-Month target
$95.25
-6.29%
Intrinsic (DCF)
$54.53
Margin of safety
-60.98%
2 Strong Buy4 Buy4 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.16 — safe zone
+ Profit margin 24.30% — above average
+ Free cash flow $12.31M — positive
+ Revenue growth 11.20% QoQ
+ Debt/equity 0.47x — low leverage
Risks
- 60.98% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $161.65M | $193.48M | $219.86M | $249.60M | $256.28M |
| Net income | $20.64M | $30.11M | $44.04M | $57.73M | $15.68M |
| EPS | — | — | — | — | $2.72 |
| Free cash flow | $22.15M | $29.49M | $37.16M | $74.47M | $12.31M |
| Profit margin | 12.77% | 15.56% | 20.03% | 23.13% | 24.30% |
Peer comparison
Smart narrative
LeMaitre Vascular Inc trades at $101.64. representing a P/E of 34.80x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 3.16, it sits in the safe zone. TTM revenue stands at $256.28M. with profit margins at 24.30%. Our DCF model estimates intrinsic value at $54.53.
Frequently asked questions
What is LeMaitre Vascular Inc's stock price?
LeMaitre Vascular Inc (LMAT) trades at $101.64, on a P/E of 34.8x and a P/S of 8.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is LeMaitre Vascular Inc overvalued?
LeMaitre Vascular Inc carries a Smart Value Score of 63/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $54.53 against the $101.64 price, so on cash flow terms the market is paying a premium for LeMaitre Vascular Inc's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of LeMaitre Vascular Inc (LMAT)?
The 12-month analyst consensus target is $118.75, about 16.8% above the current $101.64. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of LeMaitre Vascular Inc (LMAT)?
Our DCF model estimates intrinsic value at $54.53, a -61.0% margin of safety versus today's $101.64. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is LeMaitre Vascular Inc's revenue?
LeMaitre Vascular Inc's trailing twelve-month revenue is $256.28M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
LeMaitre Vascular Inc's Altman Z-Score is 3.16, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio8.44x
ROE16.60%
Beta0.60
50D MA$107.54
200D MA$94.52
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—